What is the standard recommended dosage for taking Vigabatrin/vigabatrin
Vigabatrin/vigabatrin is a gamma-aminobutyric acid transaminase (GABA-T) inhibitor, mainly used to treat refractory epilepsy, especially infantile spasms and complex partial seizures in adults that are refractory to other antiepileptic drugs. Its unique mechanism of action inhibits the degradation of GABA, thereby increasing the level of GABA in the brain, which is of great significance for controlling epileptic seizures.
In the treatment of epilepsy in adults, the standard initial recommended dose of Vigabatrin is usually 1 gram per day (divided into two doses), with subsequent dose increases based on the patient's clinical response. Usually after 1 to 2 weeks, the maintenance dose can be increased to 2 grams per day. In some refractory cases, the dose can be increased to 3 grams per day, but it is not recommended to exceed the upper limit of 3 grams per day. For pediatric patients, the dose needs to be calculated based on body weight, usually the initial dose is 40 to 50 mg/kg per day, which can be adjusted based on efficacy and tolerance, and the maximum dose does not exceed 150 mg/kg per day.

When used for the treatment of infantile spasms, the starting dose is generally 50 mg/kg per day, given in two divided doses, and can be increased to 100 to 150 mg/kg per day if necessary. In the early stage of treatment, special attention should be paid to the manifestations of adverse reactions such as vision and movement coordination.
Vigabatrin The pharmacokinetic characteristics allow it to be taken twice a day and is not affected by food, so patients can flexibly arrange their medication schedule. It is necessary to pay close attention to the reaction of the nervous system during taking, especially visual adverse events. Regular visual field testing is an important guarantee for medication safety. Generally speaking, the dose of Vigabatrin should be gradually increased in strict accordance with the doctor's instructions, and individualized adjustments should be made under professional monitoring to avoid changing the dose or frequency on your own.
Reference materials:https://www.sabril.net/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)